Raj Mehra Insider Profile

4 Followers
Raj Mehra, President, CEO and COB of Directors, Director at Seelos Therapeutics, holds 185.14K shares in Seelos Therapeutics (Ticker: SEEL), holds ― shares in ZyVersa Therapeutics (Ticker: ZVSA). Most recently, Raj Mehra Bought ― shares of Seelos Therapeutics on Dec 01, 2023 for an estimated value of 100.00K.
tipranks
Raj Mehra

Raj Mehra
Seelos Therapeutics (SEEL)
President, CEO and COB of Directors, Director

Ranked #13,140 out of 99,335 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+72.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$100K
100.00%
0.00%
A breakdown of Raj Mehra's holdings

Insider Roles

Seelos Therapeutics
(SEEL)
President, CEO and COB of Directors, Director
ZyVersa Therapeutics
(ZVSA)
Director
Roles that Raj Mehra holds in companies

Most Profitable Insider Trade

Stock:
Seelos Therapeutics
(SEEL)
Rating:Informative Buy
Date:Feb 14, 2020 - Feb 14, 2021
Return:+333.10%
The most profitable trade made by Raj Mehra

Raj Mehra's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Seelos Therapeutics
Dec 01, 2023
President, CEO and COB of Directors, Director
Informative Buy
100.00K
$99.98K
ZyVersa Therapeutics
Director
List of latest transactions for each holding click on a transaction to see Raj Mehra's performance on stock

Raj Mehra insider profile FAQ

What is the percentage of profitable transactions made by Raj Mehra?
The percentage of profitable transactions made by Raj Mehra is 33%.
    What is the average return per transaction made by Raj Mehra?
    The average return per transaction made by Raj Mehra is 72.00%.
      What stocks does Raj Mehra hold?
      Raj Mehra holds: SEEL, ZVSA stocks.
        What was Raj Mehra’s latest transaction?
        Raj Mehra latest transaction was an Informative Buy of $100.00K.
          What was Raj Mehra's most profitable transaction?
          Raj Mehra’s most profitable transaction was an Informative Buy of SEEL stock on February 14, 2020. The return on the trade was 333.10%.
            What is Raj Mehra's role in Seelos Therapeutics?
            Raj Mehra's role in Seelos Therapeutics is President, CEO and COB of Directors, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.